QTRX

Quanterix Corporation [QTRX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

QTRX Stock Summary

Top 10 Correlated Stocks

QTRX


In the News

10:51 29 Mar 2024 QTRX

Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag

Quanterix's (QTRX) blood-based biomarker test offers a non-invasive alternative, potentially revolutionizing how AD is diagnosed and managed.

06:11 29 Mar 2024 QTRX

Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.50 per share a year ago.

11:06 29 Mar 2024 QTRX

Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances

Quanterix's (QTRX) blood-based biomarker testing offers a superior alternative, aligning with the recommendations of the NIA-AA criteria for AD diagnosis.

06:58 29 Mar 2024 QTRX

Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX) today announced that it has rescheduled the release of its financial results for the fourth quarter and year ended December 31, 2023 and the associated conference call in order to more closely align the release of such results with the filing of its Annual Report on Form 10-K for the year ended December 31, 2023, the deadline for which is February 29, 2024. The investor call will now be held on Thursday, February 29, 2024.

04:30 29 Mar 2024 QTRX

Quanterix to Present at Cowen's 44th Annual Health Care Conference

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen's 44th Annual Health Care Conference. Quanterix's session will take place on Monday, March 4, 2024, at 12:50 p.m. EST and will be made available to attendees and, via webcast, the general public. In addition to the session, Quanterix will also host one-on-one me.

04:00 29 Mar 2024 QTRX

Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Tuesday, February 27, 2024, to discuss its fourth quarter earnings and full year 2023 financial results. The call will begin at 8:30 AM Eastern Time. It will be hosted by Masoud Toloue, the Company's President and Chief Executive Officer, and Vandana Sriram, the Company's Chief Financial Offi.

01:32 29 Mar 2024 QTRX

Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy

Does Quanterix Corporation (QTRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

11:17 29 Mar 2024 QTRX

Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High?

The mean of analysts' price targets for Quanterix Corporation (QTRX) points to a 54.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

03:15 29 Mar 2024 QTRX

Quanterix Corporation (QTRX) Q3 2023 Earnings Call Transcript

Quanterix Corporation (NASDAQ:QTRX ) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Ed Joyce - VP, IR Masoud Toloue - President and CEO Vandana Sriram - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Jake Allen - Goldman Sachs Dan Brennan - Cowen Puneet Souda - Leerink Partners Operator Good day and thank you for standing by. Welcome to the Quanterix Corporation Q3 2023 Earnings Call.

05:30 29 Mar 2024 QTRX

7 Stocks to Buy if You Anticipate a Hot November

While enough evidence exists that justify a pessimistic view of the market – in particular, high inflation and high borrowing costs – it's also possible that a hot November could rejuvenate previously embattled stocks to buy. And that's not an entirely speculative proposition.

QTRX Financial details

Company Rating
Neutral
Market Cap
888.02M
Income
-32.33M
Revenue
121.49M
Book val./share
9.16
Cash/share
8.48
Dividend
-
Dividend %
-
Employees
441
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-25.54
Forward P/E
-26.18
PEG
3.81
P/S
8.55
P/B
2.78
P/C
2.78
P/FCF
-49
Quick Ratio
10.01
Current Ratio
10.84
Debt / Equity
0.12
LT Debt / Equity
0.11
-
-
EPS (TTM)
-0.86
EPS next Y
-0.9
EPS next Q
-0.31
EPS this Y
-67.05%
EPS next Y
5.12%
EPS next 5Y
-82.56%
EPS last 5Y
-9.92%
Revenue last 5Y
16.38%
Revenue Q/Q
2.32%
EPS Q/Q
57.14%
-
-
-
-
SMA20
-3.78%
SMA50
-0.49%
SMA100
12.27%
Inst Own
63.9%
Inst Trans
0.73%
ROA
-9%
ROE
-11%
ROC
-0.12%
Gross Margin
57%
Oper. Margin
-40%
Profit Margin
-33%
Payout
-
Shs Outstand
38.06M
Shs Float
34.42M
-
-
-
-
Target Price
13
52W Range
10.02-29.7
52W High
-18.76%
52W Low
+135.6%
RSI
42.18
Rel Volume
1.3
Avg Volume
319.42K
Volume
414.95K
Perf Week
-12.61%
Perf Month
-4.54%
Perf Quarter
-8.93%
Perf Half Y
-7.82%
-
-
-
-
Beta
1.307
-
-
Volatility
1.07%, 1.72%
Prev Close
2.75%
Price
23.56
Change
5.65%

QTRX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.023.023.072.843.22
Net income per share
-1.45-1.1-1.6-2.61-0.86
Operating cash flow per share
-0.93-0.82-1.33-1.3-0.5
Free cash flow per share
-1.32-0.95-1.71-1.62-0.6
Cash per share
3.886.3511.019.168.55
Book value per share
4.587.2112.259.79.23
Tangible book value per share
3.736.3611.699.59.07
Share holders equity per share
4.587.2112.259.79.23
Interest debt per share
0.251.070.61.331.52
Market cap
664.29M1.33B1.53B512.32M1.03B
Enterprise value
562.8M1.18B1.15B217.69M894.86M
P/E ratio
-16.28-42.18-26.46-5.3-31.79
Price to sales ratio
11.7115.413.814.888.48
POCF ratio
-25.37-56.92-31.86-10.61-54.38
PFCF ratio
-17.94-48.72-24.81-8.54-45.3
P/B Ratio
5.166.453.461.432.96
PTB ratio
5.166.453.461.432.96
EV to sales
9.9213.6510.422.077.39
Enterprise value over EBITDA
-13.53-37.33-19.66-5.06-23.4
EV to operating cash flow
-21.49-50.46-24.04-4.51-47.34
EV to free cash flow
-15.2-43.2-18.72-3.63-39.44
Earnings yield
-0.06-0.02-0.04-0.19-0.03
Free cash flow yield
-0.06-0.02-0.04-0.12-0.02
Debt to equity
0.060.150.050.120.12
Debt to assets
0.050.110.040.10.1
Net debt to EBITDA
2.444.776.396.853.48
Current ratio
6.695.5212.1412.329.84
Interest coverage
66.35115.69145.37-14.1-3.14
Income quality
0.640.740.830.50.58
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.920.690.840.010.78
Research and developement to revenue
0.290.230.250.250.21
Intangibles to total assets
0.140.090.040.020.01
Capex to operating cash flow
0.410.170.280.240.2
Capex to revenue
-0.19-0.05-0.12-0.11-0.03
Capex to depreciation
-3.6-0.91-2.81-2.19-0.45
Stock based compensation to revenue
0.110.120.140.150.14
Graham number
12.2213.3721.0223.8913.36
ROIC
-0.3-0.12-0.12-0.16-0.12
Return on tangible assets
-0.28-0.13-0.12-0.23-0.08
Graham Net
2.894.7910.137.747.27
Working capital
112.83M179.8M411.98M350.45M339.94M
Tangible asset value
105M181.95M420.79M351.42M340.89M
Net current asset value
91.37M154.69M388.38M306.14M300.31M
Invested capital
0.060.150.050.120.12
Average receivables
8.85M14.05M20.49M21.4M22.22M
Average payables
5.44M6.29M8M6.52M4.44M
Average inventory
8.21M12.66M18.52M19.49M19.58M
Days sales outstanding
70.1672.6178.5366.1476.57
Days payables outstanding
70.5364.9768.8423.8535.62
Days of inventory on hand
127.73141.97165.88104.35157.83
Receivables turnover
5.25.034.655.524.77
Payables turnover
5.185.625.315.3110.25
Inventory turnover
2.862.572.23.52.31
ROE
-0.32-0.15-0.13-0.27-0.09
Capex per share
-0.39-0.14-0.38-0.32-0.1

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.690.760.820.820.83
Net income per share
-0.5-0.16-0.16-0.21-0.33
Operating cash flow per share
-0.11-0.250.02-0.11-0.16
Free cash flow per share
-0.15-0.260-0.13-0.22
Cash per share
9.128.828.798.78.48
Book value per share
9.669.579.489.389.16
Tangible book value per share
9.469.389.39.229
Share holders equity per share
9.669.579.489.389.16
Interest debt per share
1.261.281.161.131.42
Market cap
514.67M420.67M845.49M1.02B1.04B
Enterprise value
220.04M135.6M559.33M863.15M902.95M
P/E ratio
-6.92-17.23-34.86-32.93-20.87
Price to sales ratio
20.114.927.3933.1432.84
POCF ratio
-125.84-44.271.34K-252.41-173.11
PFCF ratio
-90.53-43.65-56.37K-211.29-126.33
P/B Ratio
1.431.182.382.892.99
PTB ratio
1.431.182.382.892.99
EV to sales
8.594.818.1227.9928.62
Enterprise value over EBITDA
-55.8-14.29-58.5-67.28-73.46
EV to operating cash flow
-53.8-14.27883.62-213.18-150.89
EV to free cash flow
-38.7-14.07-37.29K-178.45-110.12
Earnings yield
-0.04-0.01-0.01-0.01-0.01
Free cash flow yield
-0.01-0.0200-0.01
Debt to equity
0.120.120.120.120.12
Debt to assets
0.10.10.10.10.1
Net debt to EBITDA
74.7230.0529.9312.3810.82
Current ratio
12.3213.9611.8710.849.84
Interest coverage
-4.6-2.7400-1.46
Income quality
0.221.56-0.10.520.48
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.030.030.740.790.8
Research and developement to revenue
0.220.170.190.230.22
Intangibles to total assets
0.020.020.020.010.01
Capex to operating cash flow
0.390.01-1.020.190.37
Capex to revenue
-0.060-0.02-0.03-0.07
Capex to depreciation
-1.37-0.09-0.27-0.84-0.38
Stock based compensation to revenue
0.140.140.140.140.14
Graham number
10.435.935.876.68.21
ROIC
-0.03-0.02-0.02-0.03-0.04
Return on tangible assets
-0.04-0.01-0.01-0.02-0.03
Graham Net
7.77.637.557.447.22
Working capital
350.45M349.04M347.11M345.86M339.94M
Tangible asset value
351.42M350.2M348.88M347.35M340.89M
Net current asset value
306.14M305.99M305.2M305.32M300.31M
Invested capital
0.120.120.120.120.12
Average receivables
18.67M20.78M23.48M24.25M24.75M
Average payables
2.97M3.21M2.91M4.01M4.92M
Average inventory
17.51M16.93M17.61M19.05M21.16M
Days sales outstanding
66.8371.8771.270.2972.5
Days payables outstanding
26.0920.1824.5131.7924.61
Days of inventory on hand
114.17133.24137.42132.47109.03
Receivables turnover
1.351.251.261.281.24
Payables turnover
3.454.463.672.833.66
Inventory turnover
0.790.680.650.680.83
ROE
-0.05-0.02-0.02-0.02-0.04
Capex per share
-0.040-0.02-0.02-0.06

QTRX Frequently Asked Questions

What is Quanterix Corporation stock symbol ?

Quanterix Corporation is a US stock , located in Billerica of Ma and trading under the symbol QTRX

Is Quanterix Corporation buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $13. The lowest prediction is $13 and the highest is $13

What is QTRX stock prediction ?

What is Quanterix Corporation stock quote today ?

Quanterix Corporation stock price is $23.56 today.

Is Quanterix Corporation stock public?

Yes, Quanterix Corporation is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap